9999999997-15-011448.txt : 20150702 9999999997-15-011448.hdr.sgml : 20150702 20150702123534 ACCESSION NUMBER: 9999999997-15-011448 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150702 DATE AS OF CHANGE: 20150702 20150702 20150702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-27072 FILM NUMBER: 15968152 BUSINESS ADDRESS: STREET 1: 1617 JFK BLVD, SUITE #500 STREET 2: ONE PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 215-988-0080 MAIL ADDRESS: STREET 1: 1617 JFK BLVD, SUITE #500 STREET 2: ONE PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0Y(#`@;V)J#3P\+TQI;F5AF4@-C(O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XWT@P1(")-A=@,0G?@8F1H8#(%D&1G3B/^/D/P`!!@"U)@;D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HV,2`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``*>F0RH@)$! M),O1@"S&`L4,#/<9N!DXKQNU&$"5\K=#:*8[R(H5YT!$&>4!`@P`+]X&I`T* M96YD7!E+T]B M:E-T;3X^QMJ=UWXS._M9:<*(,H1;HBP1RFU2PJ50 M1#/"M>+D@=Y,IY.LR5=$2>=\]WAY2:^;95ZVA#.AZ31[^I07ZTU+M!;T0]Z9 M+A)FZ&R;K1N22#JKRG8RJ7X]7"AW#-B(8(QA@D>TSK)=L7UYMRAV>4-N\Y_D MKMIEY7NTW6:[G*+%&5#_=7XQJ;:K+PNTS]LZ;Y<;>EO5NVR+JOL.D6&,WK39 MMEA>E^MM3AB=M_GN&^&)IHN7IQQ]`7)=/+553;_WE4AEKJY;K'9'[I\!W79=I)^SWD$H1>?//UJ`LZB?<\05 MP+G,JW;3/!ACR;\4&(TD28A2BBAWZ#WI*0 MQ[!!G#Y-&#%"N"$S^/5KS7D`F=@4?6$-ME3*SA?VWL_ME=)[>;"0.&D2%:4L M#\`0I`N6+K'_QOH0TZ]MO_;V$..`)I$-0?4-0'LJB1`,OPJ^JF^.BG#X&X@[ MURE%Q"I^ZC`C`-8/R)C@?$)-WE`P`>: M-!:8@EC")!S*(].]20DRQ#PB+07Z=1S[E_2K]^F7F?/H]TWFE4>8U[+3Q"OM M2>(]EW/3_YES)1OH$Q@%;-R.GK*69U-NF$V7PPO,;BKXWIN*WX%_%XBA?U=@ ML]$;\WX0BY3+>;`%:N[C8L:5.@UD@DS;LV)@QXB`XGUPJL!B2NJS%8@''2;K9-FZ1*$"!;%'X2-8J?&UB-]E_WYGA(G3/)/GPX.Q^RD]/AK6339YA@S]/5R6E12*98 M\7BB-`LE3,/_7+),]D6>LF)YPEE0_'-R<8U[J_.4.T_U6:B$2E@Q>T-4.U'I M),_?D(R\I)`R8L44+#*C%Q9&(L\K5??\+DCX"'Y7@>;%Q3F,V&T0*EX,8%A< MW`9_%9]`)1PB<7\F\CZ.WK(R=KI)I:9]9@"Z52RRM*X<-*7\(@@3/KR[N0K" MB!?X0B.:)@$V&)TS>OTS4)(//P9AS`>C7P*[EPU_QYGK(.S#0YOMM),>]$H2 MHSUG#KN0.!?Z0D=U:S_M\)!%$&K^C6DZB_>8EBK!8Q(ACT8F]9'14B1Q5[JS M(X%,1)[4#2/G;LXI&#<,XW(S@!Q*/JK"2>%B-&O"-;H,$C;ON5J&-^Y=ZO2`J==*55>0912F19W>F/J/\AB/DR4!$O M\>T9*W&#ML[Q@8M/\'ME9^@OB:RKY?$3^KX,(C[NL2OP0!JV'3?(D ME#8`_X:TYZ$P%6G#@/@>(%0U8T#3S M!`3^BIP(:,EYN:;0T`FQC1T8"4>E(NF[TYI@4@`F0-2XAQ.`J!P!I0!18B_, MD%%=#_.]0>YNLD0@$"2V_H&XF+$Q/%?TW&P67@JQ.D:=6S^U7K'=:F:@'W&+ MI!O4HB*1^#CL+.9P60G=,(?K>%+!25=PTF^%-XR4B!N4A-'$J'Z%Z.YLA#'B MVW*%,?X2*,W9%";7L+B"WR-L*&=6$B>VY1A&"[9]0@K"67S?+OTZPRVX'76Q MTAVRQO-Q:DGRI5/`RBW#O91CU+S8[:-?B[X/T,S$_1&"B(%<4VH8Q7E.I7H! MWKQ2@YB709]/JK11,HWHFE+&*BREK@Y3P^2DLDX*:TSG$_+5LE6<4&'U-"E9 M94EY5/)?39*R1DZ!;%/G&OK4Y)T9`]BT`2]C0Q;7F`%"N(+(DZ)1H*3_:\535\>'BDZ:=S)JU"M\G[RS(.`:>,E$YB)9C,G%F`^YD-/)" M*TH9[JN7TS.YS2:T^UN@I4TG=:"^[4!.W'2@N2L_@P^&YMCN,Q_3$JA>.F4] M8QC<*",B#-EJ0072\2W.V$5?R!0!.F1E'<3_-W!9OH,)<8OZ!/1@.$:P)-&?.9PP^1S`DX8Q#7MUOB%MYX$]^M\*;D[5 M&DUA0Z0.,FA#SY9%EQA)'*^HIWC`D9(YO?K28<2"O@UY-\U^4U@4'XK*:KVM M2'+--KM)LU/!&[#^MR""DIA5]MLEV&)*C0RIV%0P'T3\D5-FM[']"W[DX'YM MJK/'\(!7[Q<=O;-T3K-FP) M^IY/\("M)6"S4FL)+W!VA5'MMRZ7=0<<`]6M"MR%04>PXDO,.R0(5`_UBA,$:&P'_.B'?M M#X3\Z`>"JKY\C&Q7&_!?%')?-*KK.?1RSQM-'#(XP59N4*R@91H.MM^K<=QL MJ$EZ\$B#%(+.CO`PKS'YD?9JNQ,6Q('NVNS\DKJKEJ:O9HU%+72_R_'#H=2R M^CCK;+]:_="]&ZGV`,Z0`FU/H/Z%/\OAS1#T!?1[>U:OT8RW5(2F-/]_>ISB M=>R!NO1FAQO,37WLKPN.[5RAT_<5T!C:6RMBXA][WX(3"1CC.K>:*_[.H(=, M=J"ZC.H(97^46K['FSTB\'[= M$F%/B0L>MO1)Z+V!-+B@J`=('@-@H);4X&4A_`>+, M\I("H#AC`I`MDI0-9H/4B62'!#D#V1U`-E]):@5(C,$YOZ"R*#,]HT3!T-+2 M4L$Q)3\I52&XLK@D-;=8P3,O.;^H(+\HL20U!:@6:@<(\+L7)58JN"?FYB8J M&.D9D>AR(@`H+"&LSR'@,&(4.X\00X#DTJ(R*).1R9B!`2#``$G&."\-"F5N M9'-T7!E+T]B:E-T;3X^?$ MX,7D:4+&4HC!2],Z\%)>$H.78;&`EV6)!+S M@`@E-L-0*+.,!"5XCV,"Z5%GQ):^3!114L`D3LBA"!11`J.XB!(YRRDFE(SS M190D2>CDQ%VA<9ZNW:H:ZG:\&>H:3?QW8%F_CE?UGH*[[I[J;U6/!D^*FWU? MN_4X[#:S[+KKQL5B0MZAYQ!,/9^#:(@:DH9,0ZZAT#"#IW;/02FL%%8**X65 MPDIAI;!26"FB%%&**$64(DH1I8A21"FB%%%*5$I42E1*5$I42E1*G"D_W(KF M#[=VZWJC'5GNGE_N_'0C)\4\=-JVW5B-3=>Z=5^U[G08FY_59G0K=];N/Z_ZM_2B?0"\=LOIYQ*V M_,F^M$]-6Z\?*UAW4'_?C=.8E@$[FU]UMQL/Z>[^93,T_3'MZ^'O@1MW;8/]7`D+1;_]2V87Y9W7ZMV^^%B^>EV_1'WXO#2MI3"X8:L],'@:5F5 M;%:*61G-RF169F9E;E869F5I[_P[3+*[%.PV!;M/P6Y4L#L5[%8%NU?!;E:P MN\5VM_@=;\KN%MO=8KM;;'>+[6ZQW2VVN\5VM\3NEMC=DG?\!=K=$KM;8G+K MMP`#`)-N>RD-"F5N9'-T7!E+UA-3"]4>7!E+TUE=&%D871A/CYS=')E86T-"CP_>'!A M8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZDY48WIK8SED M(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP M=&L](D%D;V)E(%A-4"!#;W)E(#4N-"UC,#`U(#&UL;G,Z&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O M(@H@("`@("`@("`@("!X;6QN&UL;G,Z9&,](FAT='`Z+R]P M=7)L+F]R9R]D8R]E;&5M96YT&UP.D-R96%T941A M=&4^,C`Q-2TP-RTP,E0Q,CHS,SHT,2TP-#HP,#PO>&UP.D-R96%T941A=&4^ M"B`@("`@("`@(#QX;7`Z365T861A=&%$871E/C(P,34M,#&UP34TZ1&]C=6UE;G1)1#YU=6ED.F4S M-V0Q96-E+65D-&$M-#DU-"TX-V0X+3DR8S4P83DU9#DU-CPO>&UP34TZ1&]C M=6UE;G1)1#X*("`@("`@("`@/'AM<$U-.DEN#I3;W5R8V5-;V1I9FEE9#Y$.C(P M,34P-S`R,38S,S,T/"]P9&9X.E-O=7)C94UO9&EF:65D/@H@("`@("`@("`\ M<&1F>#I#;VUP86YY/E-E8W5R:71I97,@86YD($5X:&%N9V4@0V]M;6ES#I#;VUP86YY/@H@("`@("`@("`\<&1F>#I#;VUM96YT#I#;VUM96YT7!E+T]B:E-T;3X^NS6Z(C:2MJ#_WDY$/'@+X7V?I)R!@,4B M6P;?$2?!I=F*;C>TWB5'9&?(@AR)]_:N[#,Y8!O8>(,.E-6P?G3*7A#ZDG%] M/$89E8]3K3PF]3P7F4@-#DO5'EP92]84F5F+U=;,2`R M(#%=/CYS=')E86T-"FC>8F(``B9&_G8&)@;F.T""?S608.@#$HSR0(E[;B`N M`^/P()AN``E&!H```P#+S05I#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E /9@T*,3$V#0HE)45/1@T* ` end